A DDI Study of JMKX000623 and Metformin Hydrochloride
Status:
Completed
Trial end date:
2023-11-06
Target enrollment:
Participant gender:
Summary
A phase 1, single center, 1 sequence, 3 period, open label, multiple doses study to evaluate
the drug-drug interaction of JMKX000623 tablet and metformin.